Plasma exchange therapy for the post #COVID19 condition: a phase II, double-blind, placebo-controlled, randomized trial

@ecuetosergio.bsky.social @lmateu.bsky.social @fundaciolluita.bsky.social

#LongCOVID #ClinicalTrial

🆕 El Dr. @ecuetosergio.bsky.social participarà en l’estudi #SchistoM a Zàmbia, liderat per la Dra. Amaya Bustinduy (@lshtm.bsky.social) i amb col·laboració de #Zambart.

🎯 Millorar el diagnòstic de l’esquistosomiasi genital masculina, una infecció que afecta +250M de persones al món.

Plasma exchange therapy for the post #COVID19 condition: a phase II, double-blind, placebo-controlled, randomized trial

@ecuetosergio.bsky.social @lmateu.bsky.social @fundaciolluita.bsky.social

#LongCOVID #ClinicalTrial

We just wrapped up our trial on plasmapheresis for Long COVID. The results? Not what we hoped - safe, yes, but no real benefit over placebo. Still, this is progress. Every answer, even a “no,” gets us closer to what does work! 💪🏼

@fundaciolluita.bsky.social

lluita.org/es/ensayo-cl...

Un estudi de la Fundació, publicat a @naturecomms.bsky.social, confirma que la plasmafèresi és segura, però no aporta beneficis clínics en el tractament de la #COVIDpersistent.

lluita.org/lassaig-clin...

#Recerca @lmateu.bsky.social @ecuetosergio.bsky.social

Look at this new study conducted in Nigeria, evaluating the AiDx Assist device designed to automate the detection of Schistosoma eggs in biological samples. The study and assessed the device’s performance in analyzing stool and urine samples in endemic regions 📊

www.frontiersin.org/journals/par...

🚀Thrilled to share that our article “Plasma Exchange Therapy for the Post COVID-19 Condition: a Phase II, double-blind, placebo-controlled, randomized trial” has been selected as part of Nature Communications’ Editors’ Highlights in the Microbiology and ID category!

📌 www.nature.com/collections/...

Schistosomiasis remains underdiagnosed, undertreated, and underestimated as an NTD.

In a new Lancet article Prof. Russell Stothard explores the urgent need for better diagnostics, treatment, and global investment to meet WHO’s 2030 targets.

Read his piece on this important topic: lstm.ac/4kCohK7

A new study evaluates the accuracy of 3 diagnostic tests for Schistosoma in endemic areas of Madagascar: PCR, UCP-LF CAA, and POC-CCA. The goal? Finding the most effective way to detect the infection and improve its control. Our real challenge!

idpjournal.biomedcentral.com/articles/10....

🌍✨ BUENA NOTICIA ✨
Un estudio internacional demuestra que la vacuna contra la #hepatitisE es eficaz con solo dos dosis. 

Es un gran paso en la lucha contra esta enfermedad.

👉 https://a.msf.es/435KTMA

Thrilled to share our latest study, now published in the prestigious journal Nature Communications! 📊 We conducted a phase II, double-blind, randomized, placebo-controlled trial to evaluate therapeutic plasma exchange as a potential treatment for Long COVID. 🧵👇

www.nature.com/articles/s41...

According to the 2024 @NFID survey on respiratory diseases, many people still underestimate the risks of flu, COVID-19, and RSV. Despite the high disease burden, vaccination rates remain low. Remember! Prevention is key! #PublicHealth #Vaccines

📊 Full infographic here: www.nfid.org/wp-content/u...

🚨 Big news! The EMA has issued a positive scientific opinion on a new fixed-dose combination of albendazole and ivermectin for treating soil-transmitted helminth infections and lymphatic filariasis in people aged 5 and up 🌍💊

www.global-health-edctp3.europa.eu/news-and-eve...

I’m absolutely thrilled to be a speaker at the upcoming Tropical Dermatology conference on March 14th in Madrid, collaborating with Dermalawi! I’ll be giving a talk on schistosomiasis, an important but often overlooked disease! #dermalawi #ngo #tropicalmedicine #schistosomiasis #tropicaldermatology

A recent study reports the first known human infection by Cephalobus cubaensis, a free-living nematode never before considered pathogenic to humans.

Full article: www.mdpi.com/2414-6366/10...

#Medicine #Parasitology #Science

Hey there! Just landed on Blue Sky and excited to dive into ID, Tropical Med and Global Health. So much to do-from tackling schistosomiasis to fighting antimicrobial resistance. Let’s share knowledge, exchange insights, and keep pushing forward! #infectiousdiseases #tropicawdicine #clinicalredearch